The forecasted share of corresponding/leading authorship in scientific publications in Endocrinology, Diabetes, and Metabolism in Japan remains constant at 97.65% from 2024 to 2028. This indicates a stable position from 2023, where the figure also stood at 97.65%. With no variation across the forecasted years (2024-2028), the data suggests a strong continuation of established authorship protocols, signaling potential dominance or stability in regional or institutional research practices over the five-year period.
Future trends to watch for include potential shifts in authorship dynamics due to emerging collaboration patterns, technological integration in research, and evolving international research alliances. Also, monitoring policy changes or funding adjustments could provide insights into any future variations.
